Self-Injection Market Size, Share, By Product (Needle Free Injectors, Auto injectors, Pen Injectors, and Wearable Injectors), Usability (Disposable, and Reusable), Usability (Cancer, Autoimmune Disorders, Hormonal Disorders, Pain Management, and Others), End-Users (Hospital, Specialty Clinics, and Others), and Region - Trends, Analysis, and Forecast till 2035

Report Code: PMI575425 | Publish Date: January 2025 | No. of Pages: 167

Self Injection Market Companies

  • BD
  • YPSOMED
  • West Pharmaceutical Services, Inc.
  • Haselmeier
  • NuGen Medical Devices
  • Owen Mumford Limited
  • SHL Medical
  •  PFIZER INC.
  • Amgen Inc.
  • Insulet Corporation
  • Halozyme, Inc.
  • Apikos Pharma & Penardo Biotech Pvt. Ltd.
  • Hindustan Syringes & Medical Devices Ltd
  • GSK PLC

Recent News:

  • According to a recent announcement, the FDA has approved a new single-dose, pre-filled delivery device, named SeflJect injector, to be used for Acthar Gel, a treatment indicated for a various number of chronic and acute inflammatory and autoimmune conditions, including multiple sclerosis (MS) in March 2024.
  • Novartis announced that the U.S. Food and Drug Administration (FDA) approved the supplemental Biologics License Application for Xolair (omalizumab) prefilled syringe for self-injection in appropriate patients across all approved US indications in April 2021. 1 Xolair is the only FDA-approved biologic designed to target and block immunoglobulin E (IgE) for the treatment of moderate to severe persistent allergic asthma, chronic idiopathic urticaria (CIU) and nasal polyps.